Skip to main content
IMMUNOLOGY2026™ Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

  1. Home

  • Friday, Apr 17th
    3:45 PM - 4:00 PM US ET
    PKN1 is a Novel Therapeutic Target for the Optimal Control of GvHD
    Location: 102
    Author: Jaebok Choi, PhD, MA (he/him/his) – Washington University School of Medicine, St. Louis, MO
    Transplantation Immunology (TRAN)
  • Friday, Apr 17th
    4:00 PM - 4:15 PM US ET
    IL-39/IL-39R Signaling Drives Acute Graft-versus-Host Disease by Promoting Pathogenic T-Cell Responses
    Location: 102
    Author: Denggang Fu, DF (he/him/his) – Medical College of Wisconsin
    Transplantation Immunology (TRAN)
  • Friday, Apr 17th
    4:15 PM - 4:30 PM US ET
    Evidence for Human Thymopoiesis in a Porcine Thymus Graft and T Cell Tolerance to the Source Pig in a Human Recipient of a Thymokidney Xenotransplant
    Location: 102
    Author: Farshid Fathi, PhD (he/him/his) – Columbia University
    Transplantation Immunology (TRAN)
  • Friday, Apr 17th
    4:30 PM - 4:45 PM US ET
    Coordinated circulating and tissue-based T cell responses precede xenograft rejection
    Location: 102
    Author: Ekaterina Novikova, MD – New York University Grossman School of Medicine
    Transplantation Immunology (TRAN)
  • Friday, Apr 17th
    4:45 PM - 5:00 PM US ET
    Tim-4 Effector B Cells Express a Th17-Like Proinflammatory Cytokine Module That Is Restrained by Nur77
    Location: 102
    Author: David Rothstein, MD (he/him/his) – University of Pittsburgh
    Transplantation Immunology (TRAN)
  • Friday, Apr 17th
    5:00 PM - 5:15 PM US ET
    Metabolic Regulation of Alloimmunity: Inhibition of PKM2 Attenuates T Cell Activation and Prolongs Allograft Survival
    Location: 102
    Author: Daniel Marconi Mendes, PhD (he/him/his) – Massachusetts General Hospital
    Transplantation Immunology (TRAN)